• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

"What makes a difference in chronic fatigue syndrome?": Commentary on PACE Trial mediators paper

Sean

Senior Member
Messages
7,378
This would also explain why patients are not more physically active after successful treatment of chronic fatigue syndrome: they do not necessarily have to move more, but their perception of effort and symptoms has to change.

"successful treatment" ???

I don't think that explanation explains what you think it explains.
 
Last edited:

Dolphin

Senior Member
Messages
17,567
Editorial said:
HK receives royalties as a coauthor of a treatment protocol for cognitive behaviour therapy for chronic fatigue syndrome. JW declares no competing interests.
I wonder how such royalties work? Who pays them/when do they need to be paid? e.g. is it just if another research group uses them in a study? Also what level of money are we talking about would people think?
 
Last edited:

Dolphin

Senior Member
Messages
17,567
(In case anyone missed it)
The journalist, David Tuller DrPH, has today posted a substantial piece on the PACE Trial:

TRIAL BY ERROR: The Troubling Case of the PACE Chronic Fatigue Syndrome Study
http://www.virology.ws/2015/10/21/trial-by-error-i/

There's an introduction and summary at the start if you don't want to take on the whole thing.

It's being discussed in this PR thread:
http://forums.phoenixrising.me/inde...he-pace-chronic-fatigue-syndrome-study.40664/

ME Network have also posted their own summary piece:
http://www.meaction.net/2015/10/21/david-tuller-tears-apart-pace-trial/